Epidemiology of atrial fibrillation: European perspective, Clin Epidemiol. juin, p.213, 2014. ,
Histopathological substrate for chronic atrial fibrillation in humans, Heart Rhythm. avr, vol.6, issue.4, pp.454-60, 2009. ,
Prevalence of ,
, Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
, JAMA. 9 mai, vol.285, issue.18, pp.2370-2375, 2001.
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Circulation. 11 juill, vol.114, issue.2, pp.119-144, 1980. ,
,
ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, 2016. ,
, Eur Heart J, vol.37, issue.38, pp.2893-962, 2016.
Coronary heart disease and atrial fibrillation: the Framingham Study, Am Heart J. août, vol.106, issue.2, pp.389-96, 1983. ,
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study, Circulation. 31 août, vol.110, issue.9, pp.1042-1048, 2004. ,
, Age
, Gender of Patients With Atrial Fibrillation: Analysis and Implications, Arch Intern Med. 13 mars, vol.155, issue.5, pp.469-73, 1995.
Prevalences of ECG findings in large population based samples of men and women, Heart. 1 déc, vol.84, issue.6, pp.625-658, 2000. ,
Morphology of atrial myocardium in human pulmonary veins: a postmortem analysis in patients with and without atrial fibrillation, J Am Coll Cardiol. 17 sept, vol.42, issue.6, pp.1108-1122, 2003. ,
Frequency mapping of the pulmonary veins in paroxysmal versus permanent atrial fibrillation, J Cardiovasc Electrophysiol. sept, vol.17, issue.9, pp.965-72, 2006. ,
,
, Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci, Circulation. 28 mars, vol.101, issue.12, pp.1409-1426, 2000.
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study, JAMA. 27 août, vol.290, issue.8, pp.1049-56, 2003. ,
Epidemiologic Features of Chronic ,
, Atrial Fibrillation, N Engl J Med. 29 avr, vol.306, issue.17, pp.1018-1040, 1982.
,
, Atrial Fibrillation on the Risk of Death: The Framingham Heart Study, Circulation. 8 sept, vol.98, issue.10, pp.946-52, 1998.
Mortality in an insured population with atrial fibrillation, JAMA. 17 avr, vol.245, issue.15, pp.1540-1544, 1981. ,
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation, INVESTIGATORS TAFFI OF RM (AFFIRM), vol.347, pp.1834-1874, 2002. ,
Pulse pressure and risk of new-onset atrial fibrillation, JAMA. 21 févr, vol.297, issue.7, pp.709-724, 2007. ,
Aspects électrocardiograhiques de la fibrillation auriculaire, Ann Fr Médecine Urgence. 1 janv, vol.2, issue.1, pp.27-34, 2012. ,
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation, J Am Coll Cardiol. 6 févr, vol.49, issue.5, pp.565-71, 2007. ,
,
, Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation, Circulation. 27 mai, vol.107, pp.2589-94, 1920.
Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study, Am J Respir Crit Care Med. 15 avr, vol.173, issue.8, pp.910-916, 2006. ,
,
, Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy, Circulation. 3 avr, vol.125, issue.13, pp.1605-1621, 2012.
Impact of atrial fibrillation on mortality, stroke, and medical costs, Arch Intern Med. 9 févr, vol.158, issue.3, pp.229-263, 1998. ,
,
, Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study), Am J Cardiol, vol.94, issue.7, pp.889-94, 2004.
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, Circulation. 17 juin, vol.107, issue.23, pp.2920-2925, 2003. ,
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation, Eur Heart J. nov, vol.26, issue.22, pp.2422-2456, 2005. ,
,
Newly identified events in the RE-LY trial ,
, N Engl J Med, vol.363, issue.19, pp.1875-1881, 2010.
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med. 8 sept, vol.365, issue.10, pp.883-91, 2011. ,
,
, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med. 15 sept, vol.365, issue.11, pp.981-92, 2011.
Fibrillation auriculaire non valvulaire: quelle place pour les anticoagulants oraux ? mai, 2018. ,
Apixaban in patients with atrial fibrillation, N Engl J Med. 3 mars, vol.364, issue.9, pp.806-823, 2011. ,
Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med. 17 sept, vol.361, issue.12, pp.1139-51, 2009. ,
The net clinical benefit of warfarin anticoagulation in atrial fibrillation, Ann Intern Med. 1 sept, vol.151, issue.5, pp.297-305, 2009. ,
Oral anticoagulant therapy in elderly patients, Ann Gérontologie. 1 sept, vol.3, issue.3, pp.189-96, 2010. ,
Prevalence of atrial fibrillation and eligibility for anticoagulants in the community, Arch Intern Med. 24 févr, vol.157, issue.4, pp.1167-71, 1997. ,
,
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial, Lancet Lond Engl. 10 juin, vol.367, issue.9526, pp.1903-1915, 2006. ,
,
, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med. 14 mai, vol.360, issue.20, pp.2066-78, 2009.
Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient metaanalysis, JAMA, vol.288, pp.2441-2449, 2002. ,
The role of aspirin for stroke prevention in atrial fibrillation, Nat Rev Cardiol, vol.26, issue.10, pp.602-608, 2011. ,
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation. Circulation, vol.104, pp.2118-50, 2001. ,
L'audit clinique : bases méthodologiques de l'évaluation des pratiques professionnelles, 1999. ,
Cost of care distribution in atrial fibrillation patients: the COCAF study, Am Heart J. janv, vol.147, issue.1, pp.121-127, 2004. ,
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation, JAMA. 13 juin, vol.285, issue.22, pp.2864-70, 2001. ,
Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis, Oncotarget, vol.12, issue.2017 ,
Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation: How Well Do Randomized Trials Translate Into Clinical Practice? JAMA, Am J Med. juill, vol.123, issue.7, p.2685, 2003. ,
,
, Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission, Stroke. juin, vol.31, issue.6, pp.1217-1239, 2000.
To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation, J Am Med Dir Assoc. janv, vol.7, issue.1, pp.23-31, 2006. ,
Risks of oral anticoagulant therapy with increasing age, Arch Intern Med. 11 juill, vol.165, issue.13, pp.1527-1559, 2005. ,
People aged over 75 in atrial fibrillation on warfarin: the rate of major hemorrhage and stroke in more than 500 patient-years of followup, J Am Geriatr Soc. avr, vol.53, issue.4, pp.655-664, 2005. ,
Incidence of and risk factors for atrial fibrillation in older adults, Circulation, vol.96, issue.7, pp.2455-61, 1997. ,
, Connaissez-vous les dispositifs d'auto surveillance de l'INR ? Oui Non Si oui, avez-vous des patients qui utilisent ce dispositif ? Oui Non
, Sur quels éléments cliniques et/ou biologiques reposent le suivi des ACO